GSKNEUTRAL

Gross Margin

75.4%

Higher than 73% of Healthcare sector peers

Updated 188h ago

Sector Performance

73th percentile

GSK

75.4%

Sector Median

68.9%

Sector Avg

-20.2%

📊

Deep Analysis

GSK plc (GSK) has a Gross Margin of 75.4% as of June 2026.

This places GSK in the 73th percentile of the Healthcare sector, which has a median Gross Margin of 68.9% and a sector average of -20.2%. GSK's Gross Margin is 9.4% above the sector median. In context: Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

Frequently Asked Questions

What does the Gross Margin tell investors about GSK?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does GSK's Gross Margin compare to its sector?

GSK's Gross Margin of 75.4% compares to a Healthcare sector median of 68.9%, placing it in the 73th percentile.

Who are GSK's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: AMGN (68.2%), TDOC (67.8%), TECH (66.9%), NTRA (64.8%), RMD (62.2%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.